Clinical Trial

ADO-5030 in Bronchoconstriction Challenge, Phase 1b

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated January 22, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a Phase 1 study to learn about the safety and pharmacokinetics of the study drug in patients with asthma and whether the study drug has effect during a respiratory challenge.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-01; most recent amendment 2026-01-20.
Trial Details
NCT Number NCT07281274
Lead Sponsor Adovate
Collaborators: University of Virginia
Conditions Asthma (Diagnosis)
Enrollment 36 participants
Start Date 2026-01-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-22